clinical trial · NCT02358473
Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer
Kyowa Kirin, Inc.·phase1·completed·n = 13
Non-Small Cell Lung CancermogamulizumabDocetaxel
brief summary
The purpose of this study is to evaluate the safety of mogamulizumab in combination with docetaxel in adult subjects with previously treated locally advanced or metastatic non-small cell lung cancer.
started
Jan 1, 2015
primary completion
Dec 1, 2016
completion
Dec 1, 2016
last updated
Sep 19, 2024
official title
Open-label, Multicenter Phase 1 Study of Mogamulizumab (KW-0761) in Combination With Docetaxel in Previously Treated Subjects With Non-small Cell Lung Cancer (NSCLC)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol